Sinopharm Group (OTCMKTS:SHTDY – Get Free Report) is expected to issue its results before the market opens on Monday, August 31st. Analysts expect Sinopharm Group to announce earnings of $1.25 per share and revenue of $329.0490 billion for the quarter.
Sinopharm Group Stock Up 0.4%
OTCMKTS SHTDY opened at $10.06 on Friday. The firm’s fifty day simple moving average is $10.69 and its two-hundred day simple moving average is $11.83. Sinopharm Group has a 12-month low of $9.98 and a 12-month high of $14.87.
About Sinopharm Group
Sinopharm Group Co, Ltd. (OTCMKTS:SHTDY) is one of China’s largest integrated healthcare companies and an indirect subsidiary of the state-owned China National Pharmaceutical Group Co, Ltd. The company operates through two primary segments—pharmaceutical distribution and retail pharmacy—offering comprehensive supply chain solutions that span procurement, storage, transportation and sales of medical products. With a broad portfolio that includes prescription drugs, over-the counter medicines, medical devices and consumables, Sinopharm serves hospitals, clinics, retail pharmacies and other healthcare institutions across mainland China.
In its distribution business, Sinopharm leverages an extensive logistics network, comprising hundreds of distribution centers and thousands of delivery vehicles, to ensure timely delivery of pharmaceuticals under stringent temperature-controlled conditions.
Featured Stories
- Five stocks we like better than Sinopharm Group
- From SaaS-pocalypse to Perfect Storm: Workday’s AI Growth Story Strengthens
- These 3 GARP Stocks Show Why Growth and Value Do Not Have to Clash
- Venture Into High-Volatility Corners of the Market With These 3 ETFs
- 3 Retail Stocks to Watch After a Big Consumer Earnings Week
Receive News & Ratings for Sinopharm Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sinopharm Group and related companies with MarketBeat.com's FREE daily email newsletter.
